Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Roilides

Showing results (121-130 of 337) with videos related to

Pageof 34
Sort By:
Antimicrobial Agents and Chemotherapy|June 30, 2010
Serum and cerebrospinal fluid levels of colistin in pediatric patientsCharalampos Antachopoulos, Matti Karvanen, Elias Iosifidis, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazoleCharalampos Antachopoulos, Eugenia Papakonstantinou, John Dotis, et al.
Intensive Care Medicine|June 22, 2006
Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control studyAspasia Katragkou, Maria Kotsiou, Charalampos Antachopoulos, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermumCristina Gil-Lamaignere, Emmanuel Roilides, Avgi Maloukou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
Epidemiology and clinical manifestations of mucormycosisGeorge Petrikkos, Anna Skiada, Olivier Lortholary, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic modelJoseph Meletiadis, Rafal Al-Saigh, Aristea Velegraki, et al.
Access Microbiology|September 25, 2020
Comparison of semiquantitative and differential time to positivity methods for the diagnosis of central line-associated bloodstream infections in an intensive care unitTheodoros Karampatakis, Katerina Tsergouli, Ekaterini Karantani, et al.
Medical Mycology Case Reports|June 28, 2019
Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastomaKleoniki I Athanasiadou, Dimitrios I Athanasiadis, John Constantinidis, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2008
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatusTheodouli Stergiopoulou, Joseph Meletiadis, Tin Sein, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2007
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilmsAspasia Katragkou, Athanasios Chatzimoschou, Maria Simitsopoulou, et al.
Pageof 34

Showing results (121-130 of 337) with videos related to

Sort By:
Pageof 34
Antimicrobial Agents and Chemotherapy|June 30, 2010
Serum and cerebrospinal fluid levels of colistin in pediatric patientsCharalampos Antachopoulos, Matti Karvanen, Elias Iosifidis, et al.
Journal of Pediatric Hematology/Oncology|May 14, 2005
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazoleCharalampos Antachopoulos, Eugenia Papakonstantinou, John Dotis, et al.
Intensive Care Medicine|June 22, 2006
Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control studyAspasia Katragkou, Maria Kotsiou, Charalampos Antachopoulos, et al.
The Journal of Antimicrobial Chemotherapy|December 4, 2002
Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermumCristina Gil-Lamaignere, Emmanuel Roilides, Avgi Maloukou, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
Epidemiology and clinical manifestations of mucormycosisGeorge Petrikkos, Anna Skiada, Olivier Lortholary, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2011
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic modelJoseph Meletiadis, Rafal Al-Saigh, Aristea Velegraki, et al.
Access Microbiology|September 25, 2020
Comparison of semiquantitative and differential time to positivity methods for the diagnosis of central line-associated bloodstream infections in an intensive care unitTheodoros Karampatakis, Katerina Tsergouli, Ekaterini Karantani, et al.
Medical Mycology Case Reports|June 28, 2019
Successful treatment of rhinoorbital mucormycosis due to Rhizopus arrhizus with liposomal amphotericin B, posaconazole and surgical debridement in a child with neuroblastomaKleoniki I Athanasiadou, Dimitrios I Athanasiadis, John Constantinidis, et al.
The Journal of Antimicrobial Chemotherapy|December 26, 2008
Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatusTheodouli Stergiopoulou, Joseph Meletiadis, Tin Sein, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2007
Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilmsAspasia Katragkou, Athanasios Chatzimoschou, Maria Simitsopoulou, et al.
Pageof 34